awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40444230-1C79F7B5-B368-4624-9C45-30837FB1D9D9
Q40444230-1C79F7B5-B368-4624-9C45-30837FB1D9D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40444230-1C79F7B5-B368-4624-9C45-30837FB1D9D9
Formulation studies of InhA inhibitors and combination therapy to improve efficacy against Mycobacterium tuberculosis.
P2860
Q40444230-1C79F7B5-B368-4624-9C45-30837FB1D9D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40444230-1C79F7B5-B368-4624-9C45-30837FB1D9D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3fcc4d1985f891643aa9b8fa4cce2d3bde48b49a
P2860
Drug-target residence time: critical information for lead optimization.